EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer

Shuo Wang, Xuzhi Yan, Weihua Lan, Yapeng Wang, Ze Wang, Dali Tong iD, Yao Zhang, Qiang Ran, Haoyang Li, Junhao Jin, Haiyang Xiao, Jing Xu und 8 weitere

Cancer Medicine · 2024-11 · 13 (21)

DOI: 10.1002/cam4.70398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 08.11.2024. Verfasst von Shuo Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Daping Hospital, Army Medical University, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, University Research Project of Army Medical University, Natural Science Foundation of Chongqing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB) share histomorphological and therapeutic features but distinct epidemiologic and clinicopathologic characteristics. We examined alterations of chromatin regulatory genes in molecular subtypes, clonal relatedness, and T‐cell receptor (TCR) diversity in UTUC and UCB. Materials and Methods Targeted next‐generation sequencing or whole‐exome DNA sequencing and TCR sequencing were conducted with 34 UTUC and 49 UCB specimens from 63 patients. Tumors were subtyped based on the expression of CK5 and GATA3. Results of tissue microarray of 78 muscle‐invasive bladder cancer (MIBC) samples were used as prognostic factors of different subtypes of MIBC.

Results

Chromatin regulatory genes were frequently mutated in both UTUC and UCB. Rapid relapse and progression of non‐MIBC are correlated with alterations of KMT2C and EP300 . Frequency of alterations in chromatin regulatory genes is higher in UTUC patients with SBS22 and SBS2 signatures and lower in UCB patients with SBS2 and SBS6 signatures. GATA3 and CK5 double‐positive patients with higher frequencies of SMARCA4 , ARID1A , and EP300 mutations have better prognoses than patients with basal subtypes. Although UTUC and UCB in the same patient can be either clonally related or developed independently, mutated genes in chromatin pathway were enriched in the related clones. Compared to UTUC, UCB had more deleterious mutations in DNA damage repair (DDR) genes, higher levels of tumor mutation burden (TMB) and copy number variations (CNVs), as well as higher TCR clonality and lower TCR diversity.

Conclusions

Since genetic alterations of the chromatin pathway genes are important in both UTUC and UCB, they could serve as potential biomarkers for predicting disease progression and therapeutic targets. Differences in mutation frequencies of DDR pathway, TMB, CNV, and TCR might be the contributing factors for the distinct responses to immune checkpoint inhibitor (ICI) between UTUC and UCB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsMutationHumansMaleFemaleAgedMiddle AgedCarcinoma, Transitional CellPrognosisGATA3 Transcription FactorChromatinExome SequencingAged, 80 and overBiomarkers, TumorUrologic NeoplasmsTranscription FactorsDNA HelicasesHigh-Throughput Nucleotide SequencingAdultDNA-Binding Proteins

Stichwörter der Autor:innen

chromatin regulatory genesclonal relatednessupper tract urothelial carcinomaurothelial carcinoma of bladder

Substanzen

GATA3 Transcription FactorChromatinBiomarkers, TumorTranscription FactorsDNA HelicasesGATA3 protein, humanKMT2C protein, humanARID1A protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Urology, Daping Hospital, Army Medical University, Chongqing, People's Republic of China.
  • School of Basic Medical Science, Army Medical University, Chongqing, People's Republic of China.
  • Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Pathology, Daping Hospital, Army Medical University, Chongqing, People's Republic of China.
  • CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health Sciences, Chinese Academy of Sciences, University of Chinese Acade…

ORCID-Profile: Dali Tong, Qiuli Liu

Förderung

  • National Natural Science Foundation of China
  • University Research Project of Army Medical University
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Wang, S., Yan, X., Lan, W., Wang, Y., Wang, Z., Tong, D., Zhang, Y., Ran, Q., Li, H., Jin, J., Xiao, H., Xu, J., Yan, Q., Zhang, D., Ma, Q., Xiao, H., Qin, J., Wang, L., Jiang, J., & Liu, Q. (2024). Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. Cancer Medicine, 13(21). https://doi.org/10.1002/cam4.70398

Vancouver

Wang S, Yan X, Lan W, Wang Y, Wang Z, Tong D, et al. Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. Cancer Medicine. 2024;13(21). doi:10.1002/cam4.70398

BibTeX
@article{Wang2024,
  author = {Wang, Shuo and Yan, Xuzhi and Lan, Weihua and Wang, Yapeng and Wang, Ze and Tong, Dali and Zhang, Yao and Ran, Qiang and Li, Haoyang and Jin, Junhao and Xiao, Haiyang and Xu, Jing and Yan, Qian and Zhang, Dianzheng and Ma, Qiang and Xiao, Hualiang and Qin, Jun and Wang, Luofu and Jiang, Jun and Liu, Qiuli},
  title = {Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {21},
  doi = {10.1002/cam4.70398}
}
Kostenlos starten →